Collaborative field study on the utility of a BDD factor VIII concentrate standard in the estimation of BDDr Factor VIII:C activity in hemophilic plasma using one-stage clotting assays
- 1 April 2004
- journal article
- research article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 2 (4), 623-628
- https://doi.org/10.1111/j.1538-7836.2004.00657.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- A modified thrombin generation test for the measurement of factor VIII concentratesJournal of Thrombosis and Haemostasis, 2003
- Activation profiles of factor VIII in concentrates reflect one‐stage/chromogenic potency discrepanciesBritish Journal of Haematology, 2002
- Laboratory aspects of haemophilia therapyHaemophilia, 2002
- A survey of one‐stage and chromogenic potencies in therapeutic factor VIII concentratesBritish Journal of Haematology, 2002
- Measurement of factor VIII activity of B-domain deleted recombinant factor VIIISeminars in Hematology, 2001
- Pharmacokinetics of Recombinant Factor VIII (Recombinate) Using One-stage Clotting and Chromogenic Factor VIII AssayThrombosis and Haemostasis, 1999
- Influence of phospholipids on the assessment of factor VIII activityHaemophilia, 1998
- In vivo recovery with products of very high purity — assay discrepanciesHaemophilia, 1998
- Discrepancies in potency assessment of recombinant FVIII concentratesHaemophilia, 1998